Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VITUSAPOTEK LANGHUS AS
AS
Active
Org 933820572
Parkveien 1, 1405 Langhus
Retail sale of pharmaceutical products · NACE 4773
Est. 2024
10 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 15,2M
+1091% vs 2024
EBITDA margin
-0.3%
+85% vs 2024
Equity ratio
4.6%
Financial strength
Net profit 2025
NOK -483K
-36% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 15,2M
+1091%
EBITDA
NOK -43K
+85%
Net profit
NOK -483K
-36%
Total assets
NOK 3,4M
-46%
Equity
NOK 155K
+147%
Employees
10
—
Company information
Legal name
VITUSAPOTEK LANGHUS AS
Org number
933820572
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
23. juli 2024
Share capital
NOK 1 000 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie og drive apotek og apotekrelaterte aktiviteter.
Contact
Address
Parkveien 1, 1405 Langhus
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Nordre Follo
All Norway companies
Revenue
NOK millions
0M
4M
9M
13M
17M
1M
2024
15M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
1 278
15 218
Staff expenses
−326
−2 399
EBITDA
−296
−43
Depreciation & amort.
−44
−270
EBIT
−340
−314
Net financials
−16
−170
Profit before tax
−356
−483
Tax
−0
−0
Net profit
−356
−483
Balance sheet
NOK thousands
Item
2024
2025
Total assets
6 258
3 394
Equity
−332
155
Long-term debt
3 132
0
Short-term debt
3 458
1 825
Total debt
6 590
3 239
Financial ratios
5-year trend
EBITDA margin
-0.3%
This company
15.8%
Market median
-102% vs market
2024
2025
Equity ratio
4.6%
This company
38.2%
Market median
-88% vs market
2024
2025
Return on equity
-312.2%
This company
18.4%
Market median
-1797% vs market
2024
2025
Net profit margin
-3.2%
This company
8.1%
Market median
-140% vs market
2024
2025
Asset turnover
4.48×
This company
1.12×
Market median
+300% vs market
2024
2025
Debt / equity
20.92×
This company
0.62×
Market median
-3274% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-06-25 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MM
Malik Mumtaz Hussain Taqi
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MS
Muhammad Sadiq
Chairman
2024
JF
Johan Fredrik Balstad
Board of Directors
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Farmax Holding As
Company
60%
60%
2024
Pharma Care Invest As
Company
40%
40%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Pharma Care Invest As
VITUSAPOTEK LANGHUS AS
(this company)
Board network connections
Board members of VITUSAPOTEK LANGHUS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Malik Mumtaz Hussain Taqi
Chief Executive Officer
0 companies
Muhammad Sadiq
Chairman
0 companies
Johan Fredrik Balstad
Board of Directors
0 companies